Organic compounds -- part of the class 532-570 series – Organic compounds – Chalcogen in the nitrogen containing substituent
Patent
1995-09-22
1999-07-27
Jones, Dwayne C.
Organic compounds -- part of the class 532-570 series
Organic compounds
Chalcogen in the nitrogen containing substituent
544 56, 544 57, 544 59, 544111, 544157, 544171, C07D41700, C07D41300
Patent
active
059292369
DESCRIPTION:
BRIEF SUMMARY
BACKGROUND OF THE INVENTION
The present invention relates to morpholine and thiomorpholine derivatives, pharmaceutical compositions, and methods of using such derivatives.
It is well established that there are two classes of receptors for the neurotransmitter .gamma.-aminobutyric acid (GABA), which have been identified as GABA.sub.A and GABA.sub.B. Selective GABA.sub.B agonists, such as (-)-baclofen, are known and have demonstrated clinical utility as muscle relaxants. Kerr, et al, in GABA.sub.B Receptors in Mammalian Function, Bowery, et al, eds., pp. 29-45, (Chichester 1990), have reported low affinity GABA.sub.B antagonists, such as phaclofen and 2-hydroxy saclofen. Olpe, et al, Eur. J. Pharmacol., 187, 27 (1990), discloses the GABA.sub.B antagonist 3-aminopropyl(diethoxymethyl)phosphinic acid (CGP 35348), which, although having a low receptor affinity (comparable to 2-hydroxy saclofen), can penetrate the blood/brain barrier. In addition, Hills, et al, Br. J. Pharmacol., 102, pp. 5-6 (1991) discloses phosphinic acid derivatives having activity as GABA.sub.B antagonists.
General absence (petit mal) seizures are a clinically and experimentally unique class of seizures, typically occuring in children. It has been reported that GABA.sub.B antagonists are effective in blocking the occurrence of petit mal seizures in a number of animal models: Snead III, Pharmacology Communications, 2 (1-2), pp. 63-69 (1992); Hosford, et al, Pharmacology Communications, 2 (1-2), pp. 123-124 (1992).
Mondadori, et al, Pharmacoloay Communications, 2 (1-2), pp. 93-97 (1992), disclose the use of GABA.sub.B receptor antagonists for improving cognitive performance in animal models.
Bowery, et al, Arzneim. -Forsch./Drug Res., 42 (I), Nr. 2a, pp. 215-223 (1992) relates to the physiological role of GABA.sub.B receptor antagonists.
Morpholine and thiomorpholine derivatives bearing substituents at the 2 position are known. Loftus, Syn. Comm., 10 (1), 59-73 (1980), discloses compounds of the formula ##STR2## wherein R is methyl or benzyl.
European Patent Publication EP 398426 discloses compounds of the formula ##STR3## wherein: X is O or S; P is C.sub.6 H.sub.5 --CH.sub.2 -- or C.sub.6 H.sub.5 --CH.sub.2 --O--C(O)--; R.sup.17 is C.sub.1 -C.sub.4 alkoxy or OH; W is a reactive leaving group, such as halogen or sulfonyloxy; and Het represents a heteroaryl group.
European Patent Publication EP 311948 discloses compounds of the formula ##STR4## wherein Z is a Cl, Br, I, --OSO.sub.2 CH.sub.3 or --OSO.sub.2 --C.sub.6 H.sub.4 --CH.sub.3.
SUMMARY OF THE INVENTION
Novel compounds of the present invention are represented by the formula I ##STR5## wherein: X is O or S; H, --SO.sub.2 H, --SO.sub.3 R.sup.6, --SO.sub.2 NHR.sup.7, --C(O)--N(OH)--R.sup.8, or a group of the formula ##STR6## R is selected from the group consisting of H, C.sub.1 -C.sub.8 alkyl, C.sub.1 -C.sub.8 alkanoyl, C.sub.1 -C.sub.8 alkoxycarbonyl, C.sub.3 -C.sub.8 cycloalkyl, C.sub.3 -C.sub.8 cycloalkyl(C.sub.1 -C.sub.8)alkyl, Ar--(C.sub.1 -C.sub.8)alkyl and Ar--CH.sub.2 --O--C(O)--; from C.sub.1 -C.sub.6 alkyl, halogeno, --CN, --NO.sub.2, --CF.sub.3, --OH, --OR.sup.6 and --OCF.sub.3 ; 5- or 6- position of the heterocyclic ring; hydroxy(C.sub.1 -C.sub.8)alkyl; and ##STR7## (b) X is S; or (c) Y is --SO.sub.3 H, --SO.sub.2 H, --SO.sub.3 R.sup.6, --SO.sub.2 NHR.sup.7, or a group of the formula ##STR8## R.sup.2 is selected from the group consisting of H, C.sub.1 -C.sub.8 alkyl and hydroxy(C.sub.1 -C.sub.8)alkyl; or heterocyclic ring: R.sup.1 and R.sup.2 together with the carbon atoms to which they are attached may also comprise a fused 3-8 membered carbocyclic ring, which ring may be optionally substituted by an --OH group; or heterocyclic ring: R.sup.1 and R.sup.2 together with the carbon atom to which they are attached may also comprise a 3-8 membered carbocyclic spiro ring, which ring may be optionally substituted by an --OH group; ##STR9## R.sup.8 is H, C.sub.1 -C.sub.8 alkyl, C.sub.3 -C.sub.8 cycloalkyl, C.sub.3 -C.sub.8 cycloalkyl(C.sub.1 -C.sub.8)alkyl, Ar or Ar--(C.sub.1 -C.sub
REFERENCES:
Abstract to JP 56002976, Jan. 13, 1981.
Abstract to Masuoka et al., "Syntheses of 3,4-dihydro-2H-1,4-benzoxazine-2-acetates and related compounds", Chem. Pharm. Bull., 34(1), pp. 130-139 1986.
Olpe, et al., Eur. J. Pharmacol., 187, 27-38 (1990).
Hills, et al., Br. J. Pharmacol., 102, 5-6 (1991).
Snead III, et al., Pharmacology Communications, 2, 63-69 (1992).
Hosford, et al., Pharmacology Communications, 2, 123-124 (1992).
Mondadori, et al., Pharmacology Communications, 2, 93-97 (1992).
Bowery, et al., Arzneim.-Forsch./Drug Res., 42, No. 2a, 215-223 (1992).
Loftus, Syn. Comm., 10 (1), 59-73 (1980).
Walton, et al., J. Amer. Chem. Soc., 77, 5144 (1955).
Hills, et al., Br. J. Pharmacol., 97, 1292-1296 (1989).
Hosford, et al., Pharmacology Communications, 2, 167-168 (1992).
Klebs, et al., Pharmacology Communications, 2, 171-172 (1992).
Kerr, et al., in GABA.sub.B Receptors in Mammalian Function, Bowery, et al., eds., 29-45 (Chichester 1990).
Karlsson, et al., in GABA.sub.B Receptors in Mammalian Function, Bowery, et al., eds., 349-365 (Chichester 1990).
Chem Abstracts 118: 191749p, 1993.
Blythin David J.
Kreutner William
Kuo Shen-Chun
Jones Dwayne C.
Kalyanaraman Palaiyur S.
Magatti Anita W.
Maitner John J.
Schering Corporation
LandOfFree
2-substituted morpholine and thiomorpholine derivatives as GABA- does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-substituted morpholine and thiomorpholine derivatives as GABA-, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-substituted morpholine and thiomorpholine derivatives as GABA- will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-880033